Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include RNA modifications and cancer, Cancer-related molecular mechanisms research, Immunotherapy and Immune Responses, and Cancer-related gene regulation.
Role of PD‐1 in modulating IFN‐γ‐CXCL9/10‐CXCR3 signaling in breast cancer
M7G modification of FTH1 and pri-miR-26a regulates ferroptosis and chemotherapy resistance in osteosarcoma
Association between baseline C‑reactive protein level and survival outcomes for cancer patients treated with immunotherapy: A meta‑analysis
SCN4B inhibits the progression of lung adenocarcinoma and is associated with better prognosis
METTL14 Regulates Osteogenesis of Bone Marrow Mesenchymal Stem Cells via Inducing Autophagy Through m6A/IGF2BPs/Beclin-1 Signal Axis
Colorectal leiomyosarcoma with BRCA2 mutation benefit from treatment with olaparib: a case report
Prognostic effect of TP53 mutation combined with EGFR mutation or KRAS mutation on non-small cell lung cancer.
The prognosis of EGFR complex mutation or co-mutation with tyrosine kinase inhibitor treatment in non-small cell lung cancer.
Comparative clinical analysis of fever in tumor patients, normal patients, and those infected with new coronavirus pneumonia
Correlation analysis of DDR and SWI/SNF gene mutation and the efficacy of immune checkpoint inhibitors in solid tumors.
ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1
ALKBH5 suppresses tumor progression via an m6A-dependent epigenetic silencing of pre-miR-181b-1/YAP signaling axis in osteosarcoma
METTL3 induces bone marrow mesenchymal stem cells osteogenic differentiation and migration through facilitating M1 macrophage differentiation.
PubMed 2021cited by 42position: first
ALKBH5-mediated m6A mRNA methylation governs human embryonic stem cell cardiac commitment
CircRNA_0000429 Regulates Development of NSCLC by Acting as a Sponge of miR-1197 to Control MADD
m6A Methylation of Precursor-miR-320/RUNX2 Controls Osteogenic Potential of Bone Marrow-Derived Mesenchymal Stem Cells
<p>LncRNA PTCSC3 Inhibits Tumor Growth and Cancer Cell Stemness in Gastric Cancer by Interacting with lncRNA Linc-pint</p>
Synergistic anti-tumor effects of arsenic trioxide and blue LED irradiation on human osteosarcoma
Linc‑pint overexpression inhibits the growth of gastric tumors by downregulating HIF‑1α
Activation of Dusp14 protects against osteoclast generation and bone loss by regulating AMPKα-dependent manner
Survival analysis of anticoagulant treatment of non-small cell lung cancer.
Risk factors of psychological distress and quality of life in lung cancer patients.
Comprehensive profiling and quantitation of oncogenic mutations in non–small cell lung carcinoma using single-molecule amplification and re-sequencing technology